Noninvasive assessment of liver fibrosis in patients with Fontan circulation using transient elastography and biochemical fibrosis markers

Journal of Thoracic and Cardiovascular Surgery

Volumn 135, Issue 3, 2008, Pages 560-567

  Friedrich Rust, Mireen ^a   Koch, Constanze ^b   Rentzsch, Axel ^b   Sarrazin, Christoph ^a   Schwarz, Peter ^b   Herrmann, Eva ^a   Lindinger, Angelika ^b   Sarrazin, Ulrike ^a   Poynard, Thierry ^c   Schäfers, Hans Joachim ^b   Zeuzem, Stefan ^a   Abdul Khaliq, Hashim ^a  

^a GOETHE UNIVERSITY   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; ECHOCARDIOGRAPHY; ELASTOGRAPHY; FEMALE; FONTAN PROCEDURE; HEALTH HAZARD; HEART VENTRICLE FUNCTION; HUMAN; LIVER FIBROSIS; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; ULTRASOUND; VEIN BLOOD FLOW;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY, DOPPLER; ELASTICITY IMAGING TECHNIQUES; FEMALE; FOLLOW-UP STUDIES; FONTAN PROCEDURE; HEART DEFECTS, CONGENITAL; HUMANS; INCIDENCE; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; ULTRASONOGRAPHY, DOPPLER;

EID: 40149090642     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2007.09.039     Document Type: Article

References (26)

1. Klimes K., Abdul-Khaliq H., Ovroutski S., Hui W., Alexi-Meskishvili V., Spors B., et al. Pulmonary and caval blood flow patterns in patients with intracardiac and extracardiac Fontan: a magnetic resonance study. Clin Res Cardiol 96 (2007) 160-167
2. Lunze F.I., Hui W., Abd El Rahman M.Y., Alexi-Meskishvili V., Hetzer R., Lange P.E., et al. Preserved regional atrial contractile function following extra-atrial rather than intra-atrial type Fontan operation: a tissue Doppler imaging study. Clin Res Cardiol 96 (2007) 264-271
3. Narkewicz M.R., Sondheimer H.M., Ziegler J.W., Otanni Y., Lorts A., Shaffer E.M., et al. Hepatic dysfunction following the Fontan procedure. J Pediatr Gastroenterol Nutr 36 (2003) 352-357
4. Ghaferi A.A., and Hutchins G.M. Progression of liver pathology in patients undergoing the Fontan procedure: chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. J Thorac Cardiovasc Surg 129 (2005) 1348-1352
5. Senzaki H., Masutani S., Kobayashi J., Kobayashi T., Sasaki N., Asano H., et al. Ventricular afterload and ventricular work in Fontan circulation: comparison with normal two-ventricle circulation and single-ventricle circulation with Blalock-Taussig shunts. Circulation 105 (2002) 2885-2892
6. Kiesewetter C., Sheron N., Vettukattill J., Hacking N., Stedman B., Millward-Sadler H., et al. Hepatic changes in the failing Fontan circulation. Heart 93 (2007) 579-584
7. Bravo A.A., Sheth S.G., and Chopra S. Liver biopsy. N Engl J Med 344 (2001) 495-500
8. Bedossa P., Dargere D., and Paradise V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38 (2003) 1449-1457
9. Castera L., Vergniol J., Foucher J., Le Bail B., Chanteloup E., Haaser M., et al. Prospective comparison of transient elastography, FibroTest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128 (2005) 343-350
10. De Ledinghen V., Le Bail B., Rebouissoux L., Foucher J., Castera L., Darriet M., et al. FibroScan® is a new non-invasive method for the diagnosis of liver fibrosis in children: a prospective comparison with FibroSure®, and liver biopsy. Hepatology 42 Suppl 1 (2005) 472A
11. Lebensztejn D.M., Sobaniec-Lotowska M.E., Bauer M., Kaczmarski M., Voelker M., and Schuppan D. Serum fibrosis markers as predictors of an antifibrotic effect of interferon alfa in children with chronic hepatitis B. Eur J Gastroenterol Hepatol 17 (2005) 843-848
12. Megremis S.D., Vlachonikolis I.G., and Tsilimigaki A.M. Spleen length in childhood with US: normal values based on age, sex, and somatometric parameters. Radiology 231 (2004) 129-134
13. Sandrin L., Fourquet B., Hasquenoph J.M., Yon S., Fournier C., Mal F., et al. Transient elastography: a new non-invasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 29 (2003) 1705-1713
14. Ziol M., Handra-Luca A., Kettaneh A., Christidis C., Mal F., Kazemi F., et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 41 (2005) 48-54
15. Foucher J., Chanteloup E., Vergniol J., Castera L., Le Bail B., Adhoute X., et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 55 (2006) 403-408
16. Fraquelli M., Rigamonti C., Casazza G., Conte D., Donato M.F., Ronchi G., et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 56 (2007) 968-973
17. Konate A., Boursier J., Reaud S., Quemener E., Fouchard-Hubert I., Oberti F., et al. Liver stiffness measurement by transient elastography: predictive factors of accuracy, success and reproducibility. Hepatology 44 Supp1 (2006) 452A
18. Bedossa P., and Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24 (1996) 289-293
19. Imbert-Bismut F., Messous D., Thibault V., Myers R.B., Piton A., Thabut D., et al. Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (ActiTest) and reference ranges in healthy blood donors. Clin Chem Lab Med 42 (2004) 323-333
20. Poynard T., Munteanu M., Imbert-Bismut F., Charlotte F., Thabut D., Le Calvez S., et al. Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Clin Chem 50 (2004) 1344-1355
21. Poynard T., Imbert-Bismut F., Munteanu M., Messous D., Myers R.P., Thabut D., et al. Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C. Comp Hepatol 3 (2004) 8
22. Cheung Y.F., Penny D.J., and Redington A.N. Serial assessment of left ventricular diastolic function after Fontan procedure. Heart 83 (2000) 420-424
23. Lefkowitch J.H., and Mendez L. Morphologic features of hepatic injury in cardiac disease and shock. J Hepatol 2 (1986) 313-327
24. Myers R.P., Cerini R., Sayegh R., Moreau R., Degott C., Lebrec D., et al. Cardiac hepatopathy: clinical, hemodynamic, and histologic characteristics and correlations. Hepatology 37 (2003) 393-400
25. Ngo Y., Munteanu M., Messous D., Charlotte F., Imbert-Bismut F., Thabut D., et al. A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C. Clin Chem 52 (2006) 1887-1896
26. Marino B.S. Outcomes after the Fontan procedure. Curr Opin Pediatr 14 (2002) 620-626